AML 0 3 0 3 B-cancer
, 3 4 3 4 O
ALL 5 8 5 8 B-cancer
: 8 9 8 9 O
Normal 10 16 10 16 O
values 17 23 17 23 O
for 24 27 24 27 O
absolute 28 36 28 36 B-clinical_variable
neutrophil 37 47 37 47 I-clinical_variable
count 48 53 48 53 I-clinical_variable
( 54 55 54 55 O
> 55 56 55 56 O
1000 56 60 56 60 B-lower_bound
/ 60 61 60 61 I-lower_bound
microL 61 67 61 67 I-lower_bound
) 67 68 67 68 O
and 69 72 69 72 O
platelet 73 81 73 81 B-clinical_variable
count 82 87 82 87 I-clinical_variable
( 88 89 88 89 O
> 89 90 89 90 O
100,000 90 97 90 97 B-lower_bound
/ 97 98 97 98 I-lower_bound
microL 98 104 98 104 I-lower_bound
) 104 105 104 105 O
; 105 106 105 106 O
Absence 107 114 107 114 O
of 115 117 115 117 O
extramedullary 118 132 118 132 O
leukemia 133 141 133 141 B-cancer
; 141 142 141 142 O
Less 143 147 143 147 O
than 148 152 148 152 O
5 153 154 153 154 B-upper_bound
percent 155 162 155 162 I-upper_bound
blast 163 168 163 168 I-upper_bound
cells 169 174 169 174 I-upper_bound
present 175 182 175 182 O
in 183 185 183 185 O
the 186 189 186 189 O
bone 190 194 190 194 O
marrow 195 201 195 201 O

Adequate 0 8 202 210 O
vital 9 14 211 216 O
organ 15 20 217 222 O
function 21 29 223 231 O
: 29 30 231 232 O
Left 31 35 233 237 B-clinical_variable
ventricular 36 47 238 249 I-clinical_variable
ejection 48 56 250 258 I-clinical_variable
fraction 57 65 259 267 I-clinical_variable
( 66 67 268 269 I-clinical_variable
LVEF 67 71 269 273 I-clinical_variable
) 71 72 273 274 I-clinical_variable
≥ 73 74 275 276 O
45 75 77 277 279 B-lower_bound
% 77 78 279 280 I-lower_bound
by 79 81 281 283 O
multigated 82 92 284 294 B-treatment
acquisition 93 104 295 306 I-treatment
( 105 106 307 308 I-treatment
MUGA 106 110 308 312 I-treatment
) 110 111 312 313 I-treatment
scan 112 116 314 318 I-treatment
or 117 119 319 321 O
echocardiogram 120 134 322 336 B-treatment
; 134 135 336 337 O
Forced 136 142 338 344 B-clinical_variable
expiratory 143 153 345 355 I-clinical_variable
volume 154 160 356 362 I-clinical_variable
in 161 163 363 365 I-clinical_variable
one 164 167 366 369 I-clinical_variable
second 168 174 370 376 I-clinical_variable
( 175 176 377 378 I-clinical_variable
FEV1 176 180 378 382 I-clinical_variable
) 180 181 382 383 I-clinical_variable
, 181 182 383 384 O
forced 183 189 385 391 B-clinical_variable
vital 190 195 392 397 I-clinical_variable
capacity 196 204 398 406 I-clinical_variable
( 205 206 407 408 I-clinical_variable
FVC 206 209 408 411 I-clinical_variable
) 209 210 411 412 I-clinical_variable
, 210 211 412 413 O
and 212 215 414 417 O
diffusing 216 225 418 427 B-clinical_variable
lung 226 230 428 432 I-clinical_variable
capacity 231 239 433 441 I-clinical_variable
oxygenation 240 251 442 453 I-clinical_variable
( 252 253 454 455 I-clinical_variable
DLCO 253 257 455 459 I-clinical_variable
) 257 258 459 460 I-clinical_variable
≥ 259 260 461 462 O
50 261 263 463 465 B-lower_bound
% 263 264 465 466 I-lower_bound
of 265 267 467 469 O
predicted 268 277 470 479 O
values 278 284 480 486 O
on 285 287 487 489 O
pulmonary 288 297 490 499 B-treatment
function 298 306 500 508 I-treatment
tests 307 312 509 514 I-treatment
; 312 313 514 515 O
Transaminases 314 327 516 529 B-clinical_variable
( 328 329 530 531 O
AST 329 332 531 534 B-clinical_variable
, 332 333 534 535 O
ALT 334 337 536 539 B-clinical_variable
) 337 338 539 540 O
< 339 340 541 542 O
3 341 342 543 544 B-upper_bound
times 343 348 545 550 I-upper_bound
upper 349 354 551 556 I-upper_bound
limit 355 360 557 562 I-upper_bound
of 361 363 563 565 I-upper_bound
normal 364 370 566 572 I-upper_bound
values 371 377 573 579 O
; 377 378 579 580 O
Creatinine 379 389 581 591 B-clinical_variable
clearance 390 399 592 601 I-clinical_variable
≥ 400 401 602 603 O
50cc 402 406 604 608 B-lower_bound
/ 406 407 608 609 I-lower_bound
min 407 410 609 612 I-lower_bound

Agreement 0 9 613 622 B-contraception_consent
to 10 12 623 625 I-contraception_consent
utilize 13 20 626 633 I-contraception_consent
effective 21 30 634 643 I-contraception_consent
contraceptive 31 44 644 657 I-contraception_consent
methods 45 52 658 665 O
during 53 59 666 672 O
the 60 63 673 676 O
study 64 69 677 682 O
( 70 71 683 684 O
for 71 74 684 687 O
one 75 78 688 691 O
year 79 83 692 696 O
) 83 84 696 697 O

Antithymocyte 0 13 698 711 B-treatment
globulin 14 22 712 720 I-treatment
( 23 24 721 722 I-treatment
ATG 24 27 722 725 I-treatment
) 27 28 725 726 I-treatment
as 29 31 727 729 O
part 32 36 730 734 O
of 37 39 735 737 O
the 40 43 738 741 O
conditioning 44 56 742 754 O
regimen 57 64 755 762 O

CLL 0 3 763 766 B-cancer
: 3 4 766 767 O
Absence 5 12 768 775 O
of 13 15 776 778 O
constitutional 16 30 779 793 O
symptoms 31 39 794 802 O
attributable 40 52 803 815 O
to 53 55 816 818 O
CLL 56 59 819 822 O
; 59 60 822 823 O
No 61 63 824 826 O
lymph 64 69 827 832 B-clinical_variable
nodes 70 75 833 838 I-clinical_variable
> 76 77 839 840 O
1.5 77 80 840 843 B-lower_bound
cm 81 83 844 846 I-lower_bound
in 84 86 847 849 O
diameter 87 95 850 858 B-clinical_variable
on 96 98 859 861 O
computed 99 107 862 870 B-treatment
tomography 108 118 871 881 I-treatment
; 118 119 881 882 O
No 120 122 883 885 O
hepatomegaly 123 135 886 898 O
or 136 138 899 901 O
splenomegaly 139 151 902 914 O
by 152 154 915 917 O
computed 155 163 918 926 O
tomography 164 174 927 937 O
; 174 175 937 938 O
Absolute 176 184 939 947 B-clinical_variable
neutrophil 185 195 948 958 I-clinical_variable
count 196 201 959 964 I-clinical_variable
> 202 203 965 966 O
1500 203 207 966 970 B-lower_bound
/ 207 208 970 971 I-lower_bound
microL 208 214 971 977 I-lower_bound
; 214 215 977 978 O
Platelet 216 224 979 987 B-clinical_variable
count 225 230 988 993 I-clinical_variable
> 231 232 994 995 O
100,000 232 239 995 1002 B-lower_bound
/ 239 240 1002 1003 I-lower_bound
microL 240 246 1003 1009 I-lower_bound
; 246 247 1009 1010 O
No 248 250 1011 1013 O
clonal 251 257 1014 1020 O
lymphocytes 258 269 1021 1032 O
in 270 272 1033 1035 O
the 273 276 1036 1039 O
peripheral 277 287 1040 1050 O
blood 288 293 1051 1056 O
by 294 296 1057 1059 O
immunophenotyping 297 314 1060 1077 B-treatment
; 314 315 1077 1078 O
Bone 316 320 1079 1083 O
marrow 321 327 1084 1090 O
with 328 332 1091 1095 O
no 333 335 1096 1098 O
evidence 336 344 1099 1107 O
of 345 347 1108 1110 O
clonal 348 354 1111 1117 B-cancer
CLL 355 358 1118 1121 I-cancer
( 359 360 1122 1123 O
by 360 362 1123 1125 O
flow 363 367 1126 1130 B-treatment
cytometry 368 377 1131 1140 I-treatment
and/or 378 384 1141 1147 O
immunohistochemistry 385 405 1148 1168 B-treatment

Eligible 0 8 1169 1177 O
donors 9 15 1178 1184 O
will 16 20 1185 1189 O
include 21 28 1190 1197 O
siblings 29 37 1198 1206 O
age 38 41 1207 1210 B-age
≥ 42 43 1211 1212 O
18 44 46 1213 1215 B-lower_bound
matched 47 54 1216 1223 O
with 55 59 1224 1228 O
the 60 63 1229 1232 O
recipient 64 73 1233 1242 O
at 74 76 1243 1245 O
HLA 77 80 1246 1249 O
- 80 81 1249 1250 O
A 81 82 1250 1251 O
, 82 83 1251 1252 O
B 84 85 1253 1254 O
, 85 86 1254 1255 O
C 87 88 1256 1257 O
, 88 89 1257 1258 O
and 90 93 1259 1262 O
DRB1 94 98 1263 1267 O

HIV 0 3 1268 1271 B-chronic_disease
negative 4 12 1272 1280 O
by 13 15 1281 1283 O
ELISA 16 21 1284 1289 B-treatment
or 22 24 1290 1292 O
reverse 25 32 1293 1300 B-treatment
transcription 33 46 1301 1314 I-treatment
polymerase 47 57 1315 1325 I-treatment
chain 58 63 1326 1331 I-treatment
reaction 64 72 1332 1340 I-treatment
( 73 74 1341 1342 I-treatment
RT 74 76 1342 1344 I-treatment
- 76 77 1344 1345 I-treatment
PCR 77 80 1345 1348 I-treatment
) 80 81 1348 1349 I-treatment
[ 82 83 1350 1351 O
if 83 85 1351 1353 O
ELISA 86 91 1354 1359 O
is 92 94 1360 1362 O
positive 95 103 1363 1371 O
and 104 107 1372 1375 O
RT 108 110 1376 1378 O
- 110 111 1378 1379 O
PCR 111 114 1379 1382 O
is 115 117 1383 1385 O
negative 118 126 1386 1394 O
, 126 127 1394 1395 O
the 128 131 1396 1399 O
ELISA 132 137 1400 1405 O
is 138 140 1406 1408 O
considered 141 151 1409 1419 O
false 152 157 1420 1425 O
positive 158 166 1426 1434 O
] 166 167 1434 1435 O

HL 0 2 1436 1438 O
: 2 3 1438 1439 O
No 4 6 1440 1442 O
clinical 7 15 1443 1451 O
evidence 16 24 1452 1460 O
of 25 27 1461 1463 O
disease 28 35 1464 1471 O
or 36 38 1472 1474 O
disease 39 46 1475 1482 O
- 46 47 1482 1483 O
related 47 54 1483 1490 O
symptoms 55 63 1491 1499 O
; 63 64 1499 1500 O
A 65 66 1501 1502 O
post 67 71 1503 1507 O
- 71 72 1507 1508 O
treatment 72 81 1508 1517 B-treatment
residual 82 90 1518 1526 O
mass 91 95 1527 1531 O
of 96 98 1532 1534 O
any 99 102 1535 1538 O
size 103 107 1539 1543 O
is 108 110 1544 1546 O
permitted 111 120 1547 1556 O
as 121 123 1557 1559 O
long 124 128 1560 1564 O
as 129 131 1565 1567 O
it 132 134 1568 1570 O
is 135 137 1571 1573 O
PET 138 141 1574 1577 O
negative 142 150 1578 1586 O
; 150 151 1586 1587 O
Spleen 152 158 1588 1594 O
and 159 162 1595 1598 O
liver 163 168 1599 1604 O
must 169 173 1605 1609 O
be 174 176 1610 1612 O
non 177 180 1613 1616 O
- 180 181 1616 1617 O
palpable 181 189 1617 1625 O
and 190 193 1626 1629 O
without 194 201 1630 1637 O
nodules 202 209 1638 1645 O
; 209 210 1645 1646 O
If 211 213 1647 1649 O
a 214 215 1650 1651 O
pre 216 219 1652 1655 B-treatment
- 219 220 1655 1656 I-treatment
treatment 220 229 1656 1665 I-treatment
bone 230 234 1666 1670 I-treatment
marrow 235 241 1671 1677 I-treatment
biopsy 242 248 1678 1684 I-treatment
was 249 252 1685 1688 O
positive 253 261 1689 1697 O
, 261 262 1697 1698 O
an 263 265 1699 1701 O
adequate 266 274 1702 1710 B-treatment
bone 275 279 1711 1715 I-treatment
marrow 280 286 1716 1722 I-treatment
biopsy 287 293 1723 1729 I-treatment
from 294 298 1730 1734 O
the 299 302 1735 1738 O
same 303 307 1739 1743 O
site 308 312 1744 1748 O
must 313 317 1749 1753 O
be 318 320 1754 1756 O
cleared 321 328 1757 1764 O
of 329 331 1765 1767 O
infiltrate 332 342 1768 1778 O
; 342 343 1778 1779 O
if 344 346 1780 1782 O
this 347 351 1783 1787 O
is 352 354 1788 1790 O
indeterminate 355 368 1791 1804 O
by 369 371 1805 1807 O
morphology 372 382 1808 1818 O
, 382 383 1818 1819 O
immunohistochemistry 384 404 1820 1840 B-treatment
should 405 411 1841 1847 O
be 412 414 1848 1850 O
negative 415 423 1851 1859 O

Hematologic 0 11 1860 1871 B-cancer
malignancies 12 24 1872 1884 I-cancer
- 25 26 1885 1886 O
Acute 27 32 1887 1892 B-cancer
myelogenous 33 44 1893 1904 I-cancer
leukemia 45 53 1905 1913 I-cancer
( 54 55 1914 1915 I-cancer
AML 55 58 1915 1918 I-cancer
) 58 59 1918 1919 I-cancer
, 59 60 1919 1920 O
acute 61 66 1921 1926 B-cancer
lymphoblastic 67 80 1927 1940 I-cancer
leukemia 81 89 1941 1949 I-cancer
( 90 91 1950 1951 I-cancer
ALL 91 94 1951 1954 I-cancer
) 94 95 1954 1955 I-cancer
, 95 96 1955 1956 O
myelodysplastic 97 112 1957 1972 B-cancer
syndrome 113 121 1973 1981 I-cancer
( 122 123 1982 1983 I-cancer
MDS 123 126 1983 1986 I-cancer
) 126 127 1986 1987 I-cancer
, 127 128 1987 1988 O
chronic 129 136 1989 1996 B-cancer
lymphocytic 137 148 1997 2008 I-cancer
leukemia 149 157 2009 2017 I-cancer
( 158 159 2018 2019 I-cancer
CLL 159 162 2019 2022 I-cancer
) 162 163 2022 2023 I-cancer
, 163 164 2023 2024 O
non 165 168 2025 2028 B-cancer
- 168 169 2028 2029 I-cancer
Hodgkin 169 176 2029 2036 I-cancer
lymphoma 177 185 2037 2045 I-cancer
( 186 187 2046 2047 I-cancer
NHL 187 190 2047 2050 I-cancer
) 190 191 2050 2051 I-cancer
, 191 192 2051 2052 O
Hodgkin 193 200 2053 2060 B-cancer
lymphoma 201 209 2061 2069 I-cancer
( 210 211 2070 2071 I-cancer
HL 211 213 2071 2073 I-cancer
) 213 214 2073 2074 I-cancer
, 214 215 2074 2075 O
multiple 216 224 2076 2084 B-cancer
myeloma 225 232 2085 2092 I-cancer
( 233 234 2093 2094 I-cancer
MM 234 236 2094 2096 I-cancer
) 236 237 2096 2097 I-cancer
- 238 239 2098 2099 O
in 240 242 2100 2102 O
complete 243 251 2103 2111 B-treatment
remission 252 261 2112 2121 I-treatment
( 262 263 2122 2123 I-treatment
CR 263 265 2123 2125 I-treatment
) 265 266 2125 2126 I-treatment
. 266 267 2126 2127 O
Complete 268 276 2128 2136 B-treatment
remission 277 286 2137 2146 I-treatment
is 287 289 2147 2149 O
defined 290 297 2150 2157 O
per 298 301 2158 2161 O
morphologic 302 313 2162 2173 O
, 313 314 2173 2174 O
cytogenetic 315 326 2175 2186 O
, 326 327 2186 2187 O
FISH 328 332 2188 2192 O
, 332 333 2192 2193 O
molecular 334 343 2194 2203 O
, 343 344 2203 2204 O
and 345 348 2205 2208 O
radiographic 349 361 2209 2221 O
imaging 362 369 2222 2229 O
studies 370 377 2230 2237 O
appropriate 378 389 2238 2249 O
for 390 393 2250 2253 O
each 394 398 2254 2258 O
condition 399 408 2259 2268 O
listed 409 415 2269 2275 O

Hepatitis 0 9 2276 2285 B-chronic_disease
B 10 11 2286 2287 I-chronic_disease
and 12 15 2288 2291 I-chronic_disease
C 16 17 2292 2293 I-chronic_disease
negative 18 26 2294 2302 O
by 27 29 2303 2305 O
serology 30 38 2306 2314 B-treatment
or 39 41 2315 2317 O
RT 42 44 2318 2320 B-treatment
- 44 45 2320 2321 I-treatment
PCR 45 48 2321 2324 I-treatment

MDS 0 3 2325 2328 O
: 3 4 2328 2329 O
Bone 5 9 2330 2334 B-clinical_variable
marrow 10 16 2335 2341 I-clinical_variable
with 17 21 2342 2346 O
≤5 22 24 2347 2349 O
percent 25 32 2350 2357 I-upper_bound
myeloblasts 33 44 2358 2369 I-upper_bound
with 45 49 2370 2374 O
normal 50 56 2375 2381 O
maturation 57 67 2382 2392 O
of 68 70 2393 2395 O
all 71 74 2396 2399 O
cell 75 79 2400 2404 O
lines 80 85 2405 2410 O
; 85 86 2410 2411 O
Peripheral 87 97 2412 2422 O
blood 98 103 2423 2428 O
demonstrates 104 116 2429 2441 O
hemoglobin 117 127 2442 2452 B-clinical_variable
≥11 128 131 2453 2456 O
g 132 133 2457 2458 I-lower_bound
/ 133 134 2458 2459 I-lower_bound
dL 134 136 2459 2461 I-lower_bound
, 136 137 2461 2462 O
platelets 138 147 2463 2472 B-clinical_variable
≥100 148 152 2473 2477 O
x 153 154 2478 2479 I-lower_bound
10 155 157 2480 2482 I-lower_bound
^ 157 158 2482 2483 I-lower_bound
9 158 159 2483 2484 I-lower_bound
/ 159 160 2484 2485 I-lower_bound
L 160 161 2485 2486 I-lower_bound
, 161 162 2486 2487 O
neutrophils 163 174 2488 2499 B-clinical_variable
≥1 175 177 2500 2502 O
x 178 179 2503 2504 I-lower_bound
10 180 182 2505 2507 I-lower_bound
^ 182 183 2507 2508 I-lower_bound
9 183 184 2508 2509 I-lower_bound
/ 184 185 2509 2510 I-lower_bound
L 185 186 2510 2511 I-lower_bound
, 186 187 2511 2512 O
and 188 191 2513 2516 O
no 192 194 2517 2519 O
circulating 195 206 2520 2531 O
blasts 207 213 2532 2538 O

MDS 0 3 2539 2542 B-cancer
: 3 4 2542 2543 O
Low 5 8 2544 2547 O
/ 8 9 2547 2548 O
intermediate-1 9 23 2548 2562 O
IPSS 24 28 2563 2567 O
risk 29 33 2568 2572 O
category 34 42 2573 2581 O
patients 43 51 2582 2590 O
are 52 55 2591 2594 O
eligible 56 64 2595 2603 O
only 65 69 2604 2608 O
if 70 72 2609 2611 O
they 73 77 2612 2616 O
have 78 82 2617 2621 O
failed 83 89 2622 2628 O
prior 90 95 2629 2634 B-treatment
therapy 96 103 2635 2642 I-treatment
or 104 106 2643 2645 O
are 107 110 2646 2649 O
transfusion 111 122 2650 2661 B-treatment
- 122 123 2661 2662 O
dependent 123 132 2662 2671 O

MDS 0 3 2672 2675 B-cancer
: 3 4 2675 2676 O
May 5 8 2677 2680 O
have 9 13 2681 2685 O
achieved 14 22 2686 2694 O
CR 23 25 2695 2697 O
through 26 33 2698 2705 O
either 34 40 2706 2712 O
hypomethylating 41 56 2713 2728 B-treatment
agent 57 62 2729 2734 I-treatment
therapy 63 70 2735 2742 I-treatment
, 70 71 2742 2743 O
induction 72 81 2744 2753 B-treatment
chemotherapy 82 94 2754 2766 I-treatment
, 94 95 2766 2767 O
or 96 98 2768 2770 O
other 99 104 2771 2776 B-treatment
therapy 105 112 2777 2784 I-treatment

MM 0 2 2785 2787 O
: 2 3 2787 2788 O
Absence 4 11 2789 2796 O
of 12 14 2797 2799 O
monoclonal 15 25 2800 2810 O
protein 26 33 2811 2818 O
in 34 36 2819 2821 O
serum 37 42 2822 2827 O
and 43 46 2828 2831 O
urine 47 52 2832 2837 O
by 53 55 2838 2840 O
immunofixation 56 70 2841 2855 O
with 71 75 2856 2860 O
no 76 78 2861 2863 O
current 79 86 2864 2871 O
evidence 87 95 2872 2880 O
of 96 98 2881 2883 O
soft 99 103 2884 2888 O
tissue 104 110 2889 2895 O
plasmacytoma 111 123 2896 2908 O
; 123 124 2908 2909 O
Bone 125 129 2910 2914 B-treatment
marrow 130 136 2915 2921 I-treatment
aspirate 137 145 2922 2930 I-treatment
and 146 149 2931 2934 O
biopsy 150 156 2935 2941 B-treatment
must 157 161 2942 2946 O
demonstrate 162 173 2947 2958 O
less 174 178 2959 2963 O
than 179 183 2964 2968 O
5 184 185 2969 2970 B-upper_bound
percent 186 193 2971 2978 I-upper_bound
clonal 194 200 2979 2985 O
plasma 201 207 2986 2992 O
cells 208 213 2993 2998 O
; 213 214 2998 2999 O
In 215 217 3000 3002 O
patients 218 226 3003 3011 O
who 227 230 3012 3015 O
lack 231 235 3016 3020 O
measurable 236 246 3021 3031 O
M 247 248 3032 3033 O
proteins 249 257 3034 3042 O
in 258 260 3043 3045 O
the 261 264 3046 3049 O
serum 265 270 3050 3055 O
and 271 274 3056 3059 O
urine 275 280 3060 3065 O
being 281 286 3066 3071 O
monitored 287 296 3072 3081 O
using 297 302 3082 3087 O
the 303 306 3088 3091 O
FLC 307 310 3092 3095 B-clinical_variable
levels 311 317 3096 3102 I-clinical_variable
, 317 318 3102 3103 O
the 319 322 3104 3107 O
definition 323 333 3108 3118 O
of 334 336 3119 3121 O
CR 337 339 3122 3124 O
requires 340 348 3125 3133 O
a 349 350 3134 3135 O
normalization 351 364 3136 3149 O
of 365 367 3150 3152 O
the 368 371 3153 3156 O
free 372 376 3157 3161 B-clinical_variable
light 377 382 3162 3167 I-clinical_variable
chain 383 388 3168 3173 I-clinical_variable
( 389 390 3174 3175 I-clinical_variable
FLC 390 393 3175 3178 I-clinical_variable
) 393 394 3178 3179 I-clinical_variable
ratio 395 400 3180 3185 I-clinical_variable
in 401 403 3186 3188 O
addition 404 412 3189 3197 O
to 413 415 3198 3200 O
the 416 419 3201 3204 O
above 420 425 3205 3210 O
criteria 426 434 3211 3219 O

Must 0 4 3220 3224 O
complete 5 13 3225 3233 O
full 14 18 3234 3238 O
screening 19 28 3239 3248 O
panel 29 34 3249 3254 O
: 34 35 3254 3255 O
HIV 36 39 3256 3259 B-chronic_disease
1 40 41 3260 3261 O
, 41 42 3261 3262 O
2 43 44 3263 3264 O
serology 45 53 3265 3273 O
and 54 57 3274 3277 O
RT 58 60 3278 3280 B-treatment
- 60 61 3280 3281 I-treatment
PCR 61 64 3281 3284 I-treatment
; 64 65 3284 3285 O
human 66 71 3286 3291 B-treatment
T 72 73 3292 3293 I-treatment
cell 74 78 3294 3298 I-treatment
lymphotropic 79 91 3299 3311 I-treatment
virus 92 97 3312 3317 I-treatment
types 98 103 3318 3323 I-treatment
1/2 104 107 3324 3327 I-treatment
( 108 109 3328 3329 I-treatment
HTLV-1/2 109 117 3329 3337 I-treatment
) 117 118 3337 3338 I-treatment
serology 119 127 3339 3347 I-treatment
; 127 128 3347 3348 O
rapid 129 134 3349 3354 B-treatment
plasma 135 141 3355 3361 I-treatment
reagin 142 148 3362 3368 I-treatment
( 149 150 3369 3370 I-treatment
RPR 150 153 3370 3373 I-treatment
) 153 154 3373 3374 I-treatment
serology 155 163 3375 3383 I-treatment
; 163 164 3383 3384 O
Epstein 165 172 3385 3392 B-treatment
- 172 173 3392 3393 I-treatment
Barr 173 177 3393 3397 I-treatment
virus 178 183 3398 3403 I-treatment
( 184 185 3404 3405 I-treatment
EBV 185 188 3405 3408 I-treatment
) 188 189 3408 3409 I-treatment
serology 190 198 3410 3418 I-treatment
; 198 199 3418 3419 O
Cytomegalovirus 200 215 3420 3435 B-treatment
( 216 217 3436 3437 I-treatment
CMV 217 220 3437 3440 I-treatment
) 220 221 3440 3441 I-treatment
serology 222 230 3442 3450 I-treatment
; 230 231 3450 3451 O
herpes 232 238 3452 3458 B-treatment
simplex 239 246 3459 3466 I-treatment
virus 247 252 3467 3472 I-treatment
( 253 254 3473 3474 I-treatment
HSV 254 257 3474 3477 I-treatment
) 257 258 3477 3478 I-treatment
serology 259 267 3479 3487 I-treatment
; 267 268 3487 3488 O
Varicella- 269 279 3489 3499 B-treatment
. 279 280 3499 3500 I-treatment
Zoster 281 287 3501 3507 I-treatment
Virus 288 293 3508 3513 I-treatment
( 294 295 3514 3515 I-treatment
VZV 295 298 3515 3518 I-treatment
) 298 299 3518 3519 I-treatment
serology 300 308 3520 3528 I-treatment

NHL 0 3 3529 3532 O
: 3 4 3532 3533 O
No 5 7 3534 3536 O
clinical 8 16 3537 3545 O
evidence 17 25 3546 3554 O
of 26 28 3555 3557 O
disease 29 36 3558 3565 O
or 37 39 3566 3568 O
disease 40 47 3569 3576 O
- 47 48 3576 3577 O
related 48 55 3577 3584 O
symptoms 56 64 3585 3593 O
; 64 65 3593 3594 O
Typically 66 75 3595 3604 O
FDG 76 79 3605 3608 B-treatment
- 79 80 3608 3609 I-cancer
avid 80 84 3609 3613 I-cancer
lymphomas 85 94 3614 3623 I-cancer
: 94 95 3623 3624 O
a 96 97 3625 3626 O
post 98 102 3627 3631 O
- 102 103 3631 3632 O
treatment 103 112 3632 3641 B-treatment
residual 113 121 3642 3650 O
mass 122 126 3651 3655 O
of 127 129 3656 3658 O
any 130 133 3659 3662 O
size 134 138 3663 3667 O
is 139 141 3668 3670 O
permitted 142 151 3671 3680 O
as 152 154 3681 3683 O
long 155 159 3684 3688 O
as 160 162 3689 3691 O
it 163 165 3692 3694 O
is 166 168 3695 3697 O
PET 169 172 3698 3701 O
negative 173 181 3702 3710 O
; 181 182 3710 3711 O
Variably 183 191 3712 3720 O
FDG 192 195 3721 3724 O
- 195 196 3724 3725 O
avid 196 200 3725 3729 O
lymphoma 201 209 3730 3738 O
/ 209 210 3738 3739 O
FDG 210 213 3739 3742 O
avidity 214 221 3743 3750 O
unknown 222 229 3751 3758 O
: 229 230 3758 3759 O
all 231 234 3760 3763 O
lymph 235 240 3764 3769 O
nodes 241 246 3770 3775 O
normal 247 253 3776 3782 O
size 254 258 3783 3787 O
by 259 261 3788 3790 O
CT 262 264 3791 3793 B-treatment
; 264 265 3793 3794 O
Spleen 266 272 3795 3801 O
and 273 276 3802 3805 O
liver 277 282 3806 3811 O
non 283 286 3812 3815 O
- 286 287 3815 3816 O
palpable 287 295 3816 3824 O
and 296 299 3825 3828 O
without 300 307 3829 3836 O
nodules 308 315 3837 3844 O
; 315 316 3844 3845 O
If 317 319 3846 3848 O
pretreatment 320 332 3849 3861 B-treatment
bone 333 337 3862 3866 I-treatment
marrow 338 344 3867 3873 I-treatment
biopsy 345 351 3874 3880 I-treatment
was 352 355 3881 3884 O
positive 356 364 3885 3893 O
, 364 365 3893 3894 O
repeat 366 372 3895 3901 O
bone 373 377 3902 3906 O
marrow 378 384 3907 3913 O
biopsy 385 391 3914 3920 O
must 392 396 3921 3925 O
be 397 399 3926 3928 O
negative 400 408 3929 3937 O
; 408 409 3937 3938 O
if 410 412 3939 3941 O
morphologically 413 428 3942 3957 O
indeterminate 429 442 3958 3971 O
, 442 443 3971 3972 O
immunohistochemistry 444 464 3973 3993 B-treatment
should 465 471 3994 4000 O
be 472 474 4001 4003 O
negative 475 483 4004 4012 O
If 484 486 4013 4015 O
pretreatment 487 499 4016 4028 O
bone 500 504 4029 4033 O
marrow 505 511 4034 4040 O
biopsy 512 518 4041 4047 O
was 519 522 4048 4051 O
positive 523 531 4052 4060 O
, 531 532 4060 4061 O
repeat 533 539 4062 4068 O
bone 540 544 4069 4073 O
marrow 545 551 4074 4080 O
biopsy 552 558 4081 4087 O
must 559 563 4088 4092 O
be 564 566 4093 4095 O
negative 567 575 4096 4104 O
; 575 576 4104 4105 O
if 577 579 4106 4108 O
morphologically 580 595 4109 4124 O
indeterminate 596 609 4125 4138 O
, 609 610 4138 4139 O
immunohistochemistry 611 631 4140 4160 O
should 632 638 4161 4167 O
be 639 641 4168 4170 O
negative 642 650 4171 4179 O

No 0 2 4180 4182 O
active 3 9 4183 4189 O
infection 10 19 4190 4199 B-chronic_disease
; 19 20 4199 4200 O
infection 21 30 4201 4210 O
controlled 31 41 4211 4221 O
with 42 46 4222 4226 O
antimicrobial 47 60 4227 4240 O
therapy 61 68 4241 4248 B-treatment
is 69 71 4249 4251 O
not 72 75 4252 4255 O
excluded 76 84 4256 4264 O

Performance 0 11 4265 4276 B-clinical_variable
status 12 18 4277 4283 I-clinical_variable
: 18 19 4283 4284 O
Karnofsky 20 29 4285 4294 B-clinical_variable
Performance 30 41 4295 4306 I-clinical_variable
Status 42 48 4307 4313 I-clinical_variable
Score 49 54 4314 4319 I-clinical_variable
≥ 55 56 4320 4321 O
60 57 59 4322 4324 B-lower_bound
% 59 60 4324 4325 I-lower_bound

Peripheral 0 10 4326 4336 O
blood 11 16 4337 4342 O
white 17 22 4343 4348 B-clinical_variable
blood 23 28 4349 4354 I-clinical_variable
count 29 34 4355 4360 I-clinical_variable
( 35 36 4361 4362 I-clinical_variable
WBC 36 39 4362 4365 I-clinical_variable
) 39 40 4365 4366 I-clinical_variable
greater 41 48 4367 4374 O
than 49 53 4375 4379 O
2,000 54 59 4380 4385 B-lower_bound
per 60 63 4386 4389 I-lower_bound
microliter 64 74 4390 4400 I-lower_bound
( 75 76 4401 4402 O
required 76 84 4402 4410 O
for 85 88 4411 4414 O
collection 89 99 4415 4425 O
of 100 102 4426 4428 O
dendritic 103 112 4429 4438 O
cell 113 117 4439 4443 O
precursors 118 128 4444 4454 O
) 128 129 4454 4455 O

